Literature DB >> 8203116

Reproductive failure in sows following experimental infection with a Belgian EMCV isolate.

F Koenen1, K De Clercq, J Lefebvre, R Strobbe.   

Abstract

In this study, a transplacental infection with fetal death was demonstrated following inoculation of pregnant sows with a Belgian encephalomyocarditis virus (EMCV) isolate. Eight multiparus sows were inoculated between 60 and 92 days of gestation with this EMCV-isolate to investigate its ability to cause reproductive failure in sows. Virus persistence and antibody titre in their offspring were also studied. Only the two sows inoculated at 60 days of gestation showed premature farrowing, but all sows seroconverted to EMCV. Virus was recovered from the offspring of all sows at the time of farrowing, but not from every piglet born. One month after birth EMCV could be isolated from all the piglets examined. These results can help in a better understanding of the spread of the disease in piggeries.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8203116     DOI: 10.1016/0378-1135(94)90091-4

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  12 in total

1.  Inhibition of encephalomyocarditis virus replication by shRNA targeting 1D and 3AB genes in vitro and in vivo.

Authors:  Juan Bai; Kangfu Jiang; Basit Zeshan; Xianwei Wang; Yufeng Li; Ping Jiang
Journal:  Virus Genes       Date:  2011-11-04       Impact factor: 2.332

2.  Porcine encephalomyocarditis virus persists in pig myocardium and infects human myocardial cells.

Authors:  L A Brewer; H C Lwamba; M P Murtaugh; A C Palmenberg; C Brown; M K Njenga
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

3.  Identification of encephalomyocarditis virus in clinical samples by reverse transcription-PCR followed by genetic typing using sequence analysis.

Authors:  H Vanderhallen; F Koenen
Journal:  J Clin Microbiol       Date:  1998-12       Impact factor: 5.948

4.  Rapid and sensitive polymerase chain reaction based detection and typing of foot-and-mouth disease virus in clinical samples and cell culture isolates, combined with a simultaneous differentiation with other genomically and/or symptomatically related viruses.

Authors:  W Vangrysperre; K De Clercq
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

5.  Immunogenicity and safety of virus-like particle of the porcine encephalomyocarditis virus in pig.

Authors:  Hye-Young Jeoung; Won-Ha Lee; WooSeog Jeong; Bo-Hye Shin; Hwan-Won Choi; Hee Soo Lee; Dong-Jun An
Journal:  Virol J       Date:  2011-04-15       Impact factor: 4.099

6.  Recombinant Encephalomyocarditis Viruses Elicit Neutralizing Antibodies against PRRSV and CSFV in Mice.

Authors:  Shu Zhu; Xin Guo; Lisa R Keyes; Hanchun Yang; Xinna Ge
Journal:  PLoS One       Date:  2015-06-15       Impact factor: 3.240

7.  Identification of VP1 peptides diagnostic of encephalomyocarditis virus from swine.

Authors:  Juan Bai; Xinhui Chen; Kangfu Jiang; Basit Zeshan; Ping Jiang
Journal:  Virol J       Date:  2014-12-30       Impact factor: 4.099

8.  Feeding of the probiotic bacterium Enterococcus faecium NCIMB 10415 differentially affects shedding of enteric viruses in pigs.

Authors:  Susanne Kreuzer; Patrycja Machnowska; Jens Aßmus; Matthias Sieber; Robert Pieper; Michael Fg Schmidt; Gudrun A Brockmann; Lydia Scharek-Tedin; Reimar Johne
Journal:  Vet Res       Date:  2012-07-27       Impact factor: 3.683

9.  Rodents on pig and chicken farms - a potential threat to human and animal health.

Authors:  Annette Backhans; Claes Fellström
Journal:  Infect Ecol Epidemiol       Date:  2012-02-17

10.  Modulation of the Host Lipid Landscape to Promote RNA Virus Replication: The Picornavirus Encephalomyocarditis Virus Converges on the Pathway Used by Hepatitis C Virus.

Authors:  Cristina M Dorobantu; Lucian Albulescu; Christian Harak; Qian Feng; Mirjam van Kampen; Jeroen R P M Strating; Alexander E Gorbalenya; Volker Lohmann; Hilde M van der Schaar; Frank J M van Kuppeveld
Journal:  PLoS Pathog       Date:  2015-09-25       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.